FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/12/060756 [Registered on: 26/12/2023] Trial Registered Prospectively
Last Modified On: 12/10/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Difference between effect of Ashwagandha (Withania Somnifera) and Brahmi (Bacopa monnieri Linn) on stress level and quality of sleep in patients experiencing stress.  
Scientific Title of Study   Evaluation of Comparative efficacy of Ashwagandha (Withania Somnifera) Vs Brahmi (Bacopa monnieri Linn) on stress level and quality of sleep in subjects experiencing stress. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Mohnish Gokhale 
Designation  PG Scholar 
Affiliation  Mahatma Gandhi Ayurved College salod Wardha 
Address  OPD & IPD of Kayachikitsa Department Room Number 30 Datta Meghe Institute Of Higher Education And Research Mahatma Gandhi Ayurved College And Research Centre Salod Hirapur Wardha

Wardha
MAHARASHTRA
442001
India 
Phone  8668200371  
Fax    
Email  mohnishgokhale76@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Vaishali Kuchewar 
Designation  Professor  
Affiliation  Mahatma Gandhi Ayurved College And Research Centre Salod Hirapur Wardha 
Address  OPD & IPD of Kayachikitsa Department Room Number 30 Datta Meghe Institute Of Higher Education And Research Mahatma Gandhi Ayurved College And Research Centre Salod Hirapur Wardha

Wardha
MAHARASHTRA
442001
India 
Phone  9420998747  
Fax    
Email  vkuchewar@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Mohnish Gokhale 
Designation  PG Scholar 
Affiliation  Datta Meghe Institute Of Higher Education And Research 
Address  OPD & IPD of Kayachikitsa Department Room Number 30 Datta Meghe Institute Of Higher Education And Research Mahatma Gandhi Ayurved College And Research Centre Salod Hirapur Wardha

Wardha
MAHARASHTRA
442001
India 
Phone  8668200371  
Fax    
Email  mohnishgokhale76@gmail.com  
 
Source of Monetary or Material Support  
Mahatama Gandhi Ayurved College Hospital and Research Centre 
 
Primary Sponsor  
Name  Dr Mohnish Gokhale  
Address  OPD & IPD of Kayachikitsa Department Room Number 30 Datta Meghe Institute Of Higher Education And Research Mahatma Gandhi Ayurved College And Research Centre Salod Hirapur Wardha  
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Mohnish Gokhale  Mahatama Gandhi Ayurved College Hospital and Research Centre Salod Hirapur Wardha  OPD and IPD of Department of Kayachikitsa Room No 30 Wardha
Wardha
MAHARASHTRA 
8668200371

mohnishgokhale76@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Mahatma Gandhi Ayurved College Hospital And Research Centre Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:F450||Somatization disorder. Ayurveda Condition: MANOVAHASROTOVIKARAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugOther than Classical
2Intervention ArmDrugOther than Classical(1) Medicine Name: Brahmi, Reference: NA, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/Tablets, Dose: 500(mg), Frequency: hs, Bhaishajya Kal: Adhobhakta, Duration: 60 Days, anupAna/sahapAna: Yes(details: -), Additional Information: -
3Comparator ArmDrugOther than Classical(1) Medicine Name: Ashwagandha, Reference: NA, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/Tablets, Dose: 500(mg), Frequency: hs, Bhaishajya Kal: Adhobhakta, Duration: 60 Days, anupAna/sahapAna: Yes(details: -), Additional Information: -
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  1 Body mass index 18–29 kg/m2
2 Healthy as determined by medical history physical examination, and clinical judgment of the investigator under perceived stress with a score of 14–24 on the PSS
3 Cognitively sound as confirmed by the Montreal Cognitive Assessment test
4 Willing and able to provide written informed consent and agreed to attend regular follow-ups
5 Patients with controlled NIDDM & HTN

 
 
ExclusionCriteria 
Details  1 Pregnant & lactating woman
2 Subjects with an education level below the eighth grade and unable to read
3 Subjects with any severe comorbid medical conditions or any clinically significant systemic disease with significant medication use
4 Subjects with a history of drug dependence alcohol intake or having nicotine or caffeine dependence
5 Night duty people

 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Lowering of stress level in patients of stress level in subjects experiencing stress  60 Days 
 
Secondary Outcome  
Outcome  TimePoints 
Improving of sleep quality   60 Days 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   01/01/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is Double blind randomised controlled trial  comparing the clinical efficacy of Tablet Ashwagandha 500 gm HS and Tablet Brahmi 500 mg HS for 60 days in 60 patients(30 patients in each group) the primary outcome will measure by Percieved stress scale (PSS) Montreal Cognitive assesment test Pittersberg sleep quality index (PSQI)  before and after completion of treatment 
Close